Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo.

@article{Roman2004InhibitionOP,
  title={Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo.},
  author={Brian B. Roman and Paul H. Goldspink and Elyse Spaite and Dalia Urboniene and Ronald D. McKinney and David L. Geenen and R. John Solaro and Peter Buttrick},
  journal={American journal of physiology. Heart and circulatory physiology},
  year={2004},
  volume={286 6},
  pages={
          H2089-95
        }
}
Protein kinase C (PKC) modulates cardiomyocyte function by phosphorylation of intracellular targets including myofilament proteins. Data generated from studies on in vitro heart preparations indicate that PKC phosphorylation of troponin I (TnI), primarily via PKC-epsilon, may slow the rates of cardiac contraction and relaxation (+dP/dt and -dP/dt). To explore this issue in vivo, we employed transgenic mice [mutant TnI (mTnI) mice] in which the major PKC phosphorylation sites on cardiac TnI were… 

Figures and Tables from this paper

Effects of Protein Kinase C Phosphorylation of Cardiac Troponin I:An Experimental and Model-Based Study

A modest increase in PKC-induced cTnI phosphorylation can significantly regulate cardiac muscle contraction and negative inotropy via decreased crossbridge formation and negative lusitropy via persistence of myofilament active state is revealed.

Left Ventricular and Myocardial Function in Mice Expressing Constitutively Pseudophosphorylated Cardiac Troponin I

A modest increase in PKC-induced cTnI phosphorylation can significantly alter cardiac muscle contraction: negative inotropy via decreased cross-bridge formation and negative lusitropy via persistence of myofilament active state.

Regulation of cardiac contractile function by troponin I phosphorylation.

Augmented Phosphorylation of Cardiac Troponin I in Hypertensive Heart Failure*

The data indicate that cTnI is hyperphosphorylated in the failing SHR myocardium compared with age-matched normotensive Wistar-Kyoto rats, supporting the hypothesis that PKC phosphorylation of cTNI may be maladaptive and potentially associated with cardiac dysfunction.

PKCε Increases Phosphorylation of the Cardiac Myosin Binding Protein C at Serine 302 both in Vitro and in Vivo

The data show that the Ser302 on mouse cMyBPC is a likely PKCE phosphorylation site both in vivo and in vitro and may contribute to the dilated cardiomyopathy associated with increased PKCe activity.

Augmented Protein Kinase C-α–Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure

The results suggest that in end-stage congestive heart failure, the myofilament proteins exist in a hyperphosphorylated state attributable, in part, to increased activity and signaling of PKC-α.

PICOT Inhibits Cardiac Hypertrophy and Enhances Ventricular Function and Cardiomyocyte Contractility

The inhibition of cardiac remodeling by of PicOT with a concomitant increase in ventricular function and cardiomyocyte contractility suggests that PICOT may provide an efficient modality for treatment of cardiac hypertrophy and heart failure.

TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I

  • Hui WangLin Wang Xian-min Meng
  • Biology
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • 2013
TNNI3K may be a novel mediator of cTnI phosphorylation and contribute to the regulation of cardiac myofilament contraction function.

References

SHOWING 1-10 OF 39 REFERENCES

alpha-Adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI.

Evidence is provided that specific PKC-mediated phosphorylation of Ser(43) and Ser(45) of cTnI plays an important role in regulating force development in the intact myocardium.

In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts.

In vivo PKC beta2-mediated phosphorylation of troponin I may decrease myofilament Ca2+ responsiveness, and thus causes cardiomyocyte dysfunction, and the PKCbeta selective inhibitor may provide a new therapeutic modality in the setting of heart failure.

Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites.

To determine the in vivo functional significance of troponin I (TnI) protein kinase C (PKC) phosphorylation sites, we created a transgenic mouse expressing mutant TnI, in which PKC phosphorylation

Troponin I serines 43/45 and regulation of cardiac myofilament function.

The results demonstrate the importance of PKC-mediated phosphorylation of cTnI S43/S45 in the control of myofilament activation and cross-bridge cycling rate and differential effects of agonists between WT and TGMyofilaments and within the TG my ofilaments.

Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium

The results indicate that PKC and PKA exert opposing effects on actomyosin function by phosphorylating cTnI on distinct sites, which may be to reduce the requirements of the contractile apparatus for both Ca2+ and ATP, thereby promoting efficient ATP utilisation during contraction.

Calcium-induced inotropy is in part mediated by protein kinase C.

Results indicated that exogenous Ca2+ results in translocation of PKC a from the cytoplasm to the sarcolemma and intercalated discs, as well as the translocationof PKC beta from the perinuclear to the intranuclear compartment, which resulted in myocardial inotropy.

Phosphorylation of Troponin I by Protein Kinase A Accelerates Relaxation and Crossbridge Cycle Kinetics in Mouse Ventricular Muscle

It is concluded that the acceleration of myofibrillar relaxation rate by PKA is due to phosphorylation of TnI, rather than MyBP-C, and that this may be due, at least in part, to faster crossbridge cycle kinetics.

Phosphorylation of Troponin I Controls Cardiac Twitch Dynamics: Evidence From Phosphorylation Site Mutants Expressed on a Troponin I-Null Background in Mice

It is proposed that &bgr;-agonists and endothelin-1 regulate cardiac twitch dynamics in opposite directions in part through phosphorylation of the myofilament protein cTnI on distinct sites.

Troponin I phosphorylation enhances crossbridge kinetics during β‐adrenergic stimulation in rat cardiac tissue

TnI phosphorylation, mediated by cAMP‐dependent protein kinase A, is the molecular basis for the enhanced crossbridge cycling seen during β‐adrenergic stimulation of the heart.

PKC translocation without changes in Gαq and PLC-β protein abundance in cardiac hypertrophy and failure.

Differential PKC activation may be mediated by increases in Gαq and PLC-βI activity rather than upregulation of expression, andTranslocation of PKC-α, -ε, and -γ from cytosolic to membranous fractions were significantly increased during POH and CHF.